About this episode

This episode explores the potential of gene therapy and precision psychiatry in treating anxiety, featuring insights from neuroscientist Dr. Troy Rohn.

Anxiety is one of the most common mental health conditions, but for many people, it can also feel deeply isolating. Current treatments such as therapy, SSRIs, and benzodiazepines can be life-changing, but they do not work for everyone, and they often manage symptoms rather than addressing the underlying biology of anxiety. In this episode of DNA Today, host Kira Dineen is joined by Dr. Troy Rohn, neuroscientist, professor at Boise State University, and Co-founder and Director of Preclinical Studies at Cognigenics. Dr. Rohn is also the author of Brain Medicine: Breakthroughs in Gene Therapy for Anxiety & Other Neuropsychiatric Disorders, a brand new book exploring how CRISPR, RNA interference, neurogenetics, and precision psychiatry could reshape the future of mental health treatment. We take a deeply personal and scientific look at anxiety. Dr. Rohn shares how his own experiences with chronic anxiety and PTSD helped inspire his work, while also explaining the brain biology behind anxiety, including the roles of serotonin, GABA, the amygdala, hippocampus, insula, and thalamus. A major focus of the episode is the 5-HT2A serotonin receptor, produced through the HTR2A gene, and…

More episodes of DNA Today: A Genetics Podcast

• #397 ABGC Recertification Changes: Learning Scenarios Explained for Genetic Counselors · June 5, 2026 · 32 min
• #395 Mapping Melanoma: How Spatial Biology Is Advancing Cancer Research · May 22, 2026 · 28 min
• #394 How Newborn Sequencing Could Transform Pediatric Rare Disease Care in Florida · May 15, 2026 · 33 min

Explore listener stats, chart rankings, contacts and more on the DNA Today: A Genetics Podcast podcast page.